Advertisement
Loading...

QHSLab, Inc.

USAQPNK
Healthcare
Medical - Devices
$0.57
$0.10(21.98%)
U.S. Market opens in 6h 31m
Advertisement

QHSLab, Inc. Fundamental Analysis

QHSLab, Inc. (USAQ) shows strong financial fundamentals with a PE ratio of 19.64, profit margin of 15.61%, and ROE of 91.63%. The company generates $0.0B in annual revenue with strong year-over-year growth of 51.31%.

Key Strengths

ROE91.63%
PEG Ratio0.13
Current Ratio1.68

Areas of Concern

Operating Margin1.76%
We analyze USAQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 79.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
79.3/100

We analyze USAQ's fundamental strength across five key dimensions:

Efficiency Score

Excellent

USAQ demonstrates superior asset utilization.

ROA > 10%
22.93%

Valuation Score

Excellent

USAQ trades at attractive valuation levels.

PE < 25
19.64
PEG Ratio < 2
0.13

Growth Score

Excellent

USAQ delivers strong and consistent growth momentum.

Revenue Growth > 5%
51.31%
EPS Growth > 10%
49.30%

Financial Health Score

Excellent

USAQ maintains a strong and stable balance sheet.

Debt/Equity < 1
0.09
Current Ratio > 1
1.68

Profitability Score

Excellent

USAQ achieves industry-leading margins.

ROE > 15%
91.63%
Net Margin ≥ 15%
15.61%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is USAQ Expensive or Cheap?

P/E Ratio

USAQ trades at 19.64 times earnings. This indicates a fair valuation.

19.64

PEG Ratio

When adjusting for growth, USAQ's PEG of 0.13 indicates potential undervaluation.

0.13

Price to Book

The market values QHSLab, Inc. at 5.59 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.59

EV/EBITDA

Enterprise value stands at 10.49 times EBITDA. This signals the market has high growth expectations.

10.49

How Well Does USAQ Make Money?

Net Profit Margin

For every $100 in sales, QHSLab, Inc. keeps $15.61 as profit after all expenses.

15.61%

Operating Margin

Core operations generate 1.76 in profit for every $100 in revenue, before interest and taxes.

1.76%

ROE

Management delivers $91.63 in profit for every $100 of shareholder equity.

91.63%

ROA

QHSLab, Inc. generates $22.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

22.93%

Following the Money - Real Cash Generation

Operating Cash Flow

QHSLab, Inc. generates limited operating cash flow of $22.40K, signaling weaker underlying cash strength.

$22.40K

Free Cash Flow

QHSLab, Inc. generates weak or negative free cash flow of $22.40K, restricting financial flexibility.

$22.40K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

USAQ converts 0.67% of its market value into free cash.

0.67%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

19.64

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.50

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.68

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.92

vs 25 benchmark

ROA

Return on assets percentage

0.23

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How USAQ Stacks Against Its Sector Peers

MetricUSAQ ValueSector AveragePerformance
P/E Ratio19.6428.32 Better (Cheaper)
ROE91.63%733.00% Weak
Net Margin15.61%-53055.00% (disorted) Strong
Debt/Equity0.090.38 Strong (Low Leverage)
Current Ratio1.684.03 Neutral
ROA22.93%-19488.00% (disorted) Strong

USAQ outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews QHSLab, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

18.13%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

155.55%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ